The Federal Trade Commission published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ influence over specialty generic ...
PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...
Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
When talking about the influence of pharmacy benefit managers, U.S. Sen. James Lankford exhibits a mastery of how companies like CVS Health control where patients get their medicine, what ...
Walgreens-Boots Alliance struggles with margin compression, competition, and financial risks. Learn why these challenges make ...
Federal Trade Commission chairman Andrew Ferguson called for eliminating legal protections that prevent presidents from ...
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
To The Watchdog, it marked the Golden Era of consumer protection. It was as if the staffers that enforce rules and laws ...